171 related articles for article (PubMed ID: 348094)
1. Gentamicin use and Pseudomonas and Serratia resistance: effect of a surgical prophylaxis regimen.
Roberts NJ; Douglas RG
Antimicrob Agents Chemother; 1978 Feb; 13(2):214-20. PubMed ID: 348094
[TBL] [Abstract][Full Text] [Related]
2. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
Schassan HH
Infection; 1976; 4(2):35-41. PubMed ID: 789246
[TBL] [Abstract][Full Text] [Related]
3. Patient factors contributing to the emergence of gentamicin-resistant Serratia marcescens.
Yu VL; Oakes CA; Axnick KJ; Merigan TC
Am J Med; 1979 Mar; 66(3):468-72. PubMed ID: 373434
[TBL] [Abstract][Full Text] [Related]
4. Hospital isolates of Serratia marcescens transferring ampicillin, carbenicillin, and gentamicin resistance to other gram-negative bacteria including Pseudomonas aeruginosa.
Olexy VM; Bird TJ; Grieble HG; Farrand SK
Antimicrob Agents Chemother; 1979 Jan; 15(1):93-100. PubMed ID: 106772
[TBL] [Abstract][Full Text] [Related]
5. Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital.
Meyer RD; Lewis RP; Halter J; White M
Lancet; 1976 Mar; 1(7959):580-3. PubMed ID: 55850
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
Yourassowsky E; Schoutens E; Vanderlinden MP
Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
[TBL] [Abstract][Full Text] [Related]
7. Serratia marcescens as a postoperative pathogen.
Williams TW; Sailer JE; Viroslav J; Knight V; Glasgow N; Moreland N
Am J Surg; 1971 Jul; 122(1):64-9. PubMed ID: 4326385
[No Abstract] [Full Text] [Related]
8. Gentamicin-resistant Serratia marcescens endophthalmitis.
Gammon JA; Schwab I; Joseph P
Arch Ophthalmol; 1980 Jul; 98(7):1221-3. PubMed ID: 6994702
[TBL] [Abstract][Full Text] [Related]
9. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
Leonard JM; McGee ZA; Alford RH
Arch Intern Med; 1978 Feb; 138(2):201-5. PubMed ID: 415674
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of Serratia marcescens containing a plasmid coding for gentamicin resistance in nosocomial infections.
John JF; McNeill WF
J Infect Dis; 1981 Jun; 143(6):810-7. PubMed ID: 7019356
[TBL] [Abstract][Full Text] [Related]
11. Gentamicin treatment associated with later nosocomial gentamicin-resistant Serratia marcescens infections.
Graham DR; Clegg HW; Anderson RL; Chelgren GA; Mostow SR; Dixon RE
Infect Control; 1981; 2(1):31-7. PubMed ID: 7012063
[TBL] [Abstract][Full Text] [Related]
12. Loss of an aminoglycoside resistance plasmid by Serratia marcescens during treatment of meningitis with amikacin.
Rubens CE; McGee ZA; Farrar WE
J Infect Dis; 1980 Mar; 141(3):346-50. PubMed ID: 6988523
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
Watanakunakorn C; Kauffman CA
Infection; 1978; 6(3):111-5. PubMed ID: 98451
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate.
Traub WH; Raymond EA
Appl Microbiol; 1972 Jan; 23(1):4-7. PubMed ID: 4621796
[TBL] [Abstract][Full Text] [Related]
15. Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organisms.
Yu VL; Rhame FS; Pesanti EL; Axline SG
JAMA; 1977 Aug; 238(9):943-7. PubMed ID: 328950
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin resistant Serratia marcescens endocarditis as a complication of non-Hodgkin's lymphoma.
Körner RJ; Nicol A; Reeves DS; MacGowan AP; Hows J
J Infect; 1994 Jul; 29(1):73-6. PubMed ID: 7963638
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus spp.
Livingston WK; Elliott AM; Cobbs CG
Antimicrob Agents Chemother; 1981 Jan; 19(1):114-6. PubMed ID: 6787975
[TBL] [Abstract][Full Text] [Related]
18. Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital.
Wilfert JN; Barrett FF; Ewing WH; Finland M; Kass EH
Appl Microbiol; 1970 Feb; 19(2):345-52. PubMed ID: 4314379
[TBL] [Abstract][Full Text] [Related]
19. Gentamicin. Clinical and pharmacological studies.
Holloway WJ
Int Z Klin Pharmakol Ther Toxikol; 1970 May; 3(2):122-7. PubMed ID: 4913081
[No Abstract] [Full Text] [Related]
20. R plasmids coding for gentamicin, tobramycin, and carbenicillin resistance in Serratia, Klebsiella and Escherichia coli strains from a single clinical source.
Knothe H; Kettner M; Kopsová D; Krcméry V
Chemotherapy; 1977; 23(1):37-43. PubMed ID: 401718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
